Biomanufacturing Units
Introduction to BiomanufacturingUpstream ProcessingDownstream ProcessingBiomanufacture of Monoclonal AntibodiesQuality AssuranceQuality Control BiochemistryMicrobiological ControlProcess DevelopmentManufacture of a Drug ProductFacilitiesMetrologyValidationEnvironmental Health & SafetyOperational ExcellenceBiofuels
mini-BIOMAN Conferences
miniBIOMAN 2019: Design of Experiments for BiomanufacturingminiBIOMAN 2019: Quality in BiomanufacturingminiBIOMAN 2018: Downstream Processing of mAbsminiBIOMAN 2018: Incorporating Undergraduate Research in Process DevelopmentminiBIOMAN 2017: Manufacture of a Drug Product - Final Fill Finishmini-BIOMAN 2017: Upstream Processing- Mab Production in CHO cellsmini-BIOMAN 2017: Single Use Technology in Biomanufacturingmini-BIOMAN 2016: Stem Cell Production in a Regulated Environment
UPCOMING 2019 BIOTECHNOLOGY CONFERENCES, MEETINGS, AND FELLOWSHIPS
View Upcoming Events
This article explores the challenges and potential of next-generation therapeutic antibodies.
Read Article Here
GEN‘s contributing editor K. John Morrow, Jr., PhD, recently spoke with several industry leaders to discuss the issue of bottlenecks in the...
View Here
Who's paying the price tag for big pharma's big bet, which hasn't delivered impressive returns? Look in the mirror.
Go to Article
Article highlights some of today’s top trends in bioprocessing.
View Life Science Leader Magazine
Newark, Del., July 31, 2019 – The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) announced that the University of...
Read Article Here
It’s not surprising that Steven Yatomi-Clarke started his second career at a company named Prescient Therapeutics. In his first career as an...
Read Article Here
The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) releases technology roadmaps for ADC/Biospecifics, Gene Therapy,...
View niimbl.org
Evolution Global’s ongoing BioManufacturing series provides an exclusive, in-depth analysis of key trends that will shape the future of biologic...
View Evolution Global - Evobiotalent.com
Doctors at the Mayo Clinic have received FDA approval for a platform that can manufacture stem cells by the billions in just days, in contrast to...
View futurism.com
This week, we examine an up-and-coming alternative to the amazing, somewhat problematic mAb: DARPins—Designed Ankyrin Repeat Proteins. This new type...
Read Article Here
There is much work to do to achieve efficient, cost-effective production processes
View BioPharm International.com
Using continuous processing instead of batch-based processing provides therapeutic manufacturers with a number of advantages. For example, the...
View Article
Whether improvements in the delivery of training in biopharmaceutical manufacturing are needed is an open question, and the answers are not clear-cut...
View Life Science Leader Magazine
The CHO cell is at its height of technological prominence thanks to its adaptability to various culture conditions and plasticity in the context of...
View CHO Consortium SBE Special Section
The Keck Graduate Institute and WuXi Biologics have teamed together to provide technical training videos for the bioprocessing industry. These are 2...
View Wuxibiologics.com